Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Century Therapeutics (IPSC) Debt Ratio (2022 - 2025)

Historic Debt Ratio for Century Therapeutics (IPSC) over the last 3 years, with Q3 2025 value amounting to 0.03.

  • Century Therapeutics' Debt Ratio changed N/A to 0.03 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03, marking a year-over-year change of. This contributed to the annual value of 0.02 for FY2022, which is N/A changed from last year.
  • Per Century Therapeutics' latest filing, its Debt Ratio stood at 0.03 for Q3 2025.
  • Century Therapeutics' Debt Ratio's 5-year high stood at 0.03 during Q3 2025, with a 5-year trough of 0.02 in Q1 2022.
  • Its 3-year average for Debt Ratio is 0.02, with a median of 0.02 in 2022.
  • Data for Century Therapeutics' Debt Ratio shows a peak YoY increase of 2398.06% (in 2023) and a maximum YoY decrease of 2398.06% (in 2023) over the last 5 years.
  • Quarter analysis of 3 years shows Century Therapeutics' Debt Ratio stood at 0.02 in 2022, then increased by 7.23% to 0.02 in 2023, then surged by 50.96% to 0.03 in 2025.
  • Its Debt Ratio stands at 0.03 for Q3 2025, versus 0.02 for Q1 2023 and 0.02 for Q4 2022.